- Home
- STOK vs JKS Comparison
STOK vs JKS Comparison
Compare STOK & JKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STOK
- JKS
- Stock Information
- Founded
- STOK 2014
- JKS 2006
- Country
- STOK United States
- JKS China
- Employees
- STOK N/A
- JKS N/A
- Industry
- STOK Biotechnology: Pharmaceutical Preparations
- JKS Semiconductors
- Sector
- STOK Health Care
- JKS Technology
- Exchange
- STOK Nasdaq
- JKS Nasdaq
- Market Cap
- STOK 1.3B
- JKS 1.3B
- IPO Year
- STOK 2019
- JKS 2010
- Fundamental
- Price
- STOK $22.74
- JKS $25.35
- Analyst Decision
- STOK Strong Buy
- JKS Sell
- Analyst Count
- STOK 6
- JKS 4
- Target Price
- STOK $26.60
- JKS $28.99
- AVG Volume (30 Days)
- STOK 893.3K
- JKS 564.4K
- Earning Date
- STOK 11-04-2025
- JKS 10-29-2025
- Dividend Yield
- STOK N/A
- JKS 5.93%
- EPS Growth
- STOK N/A
- JKS N/A
- EPS
- STOK 0.91
- JKS N/A
- Revenue
- STOK $199,893,000.00
- JKS $11,445,691,729.00
- Revenue This Year
- STOK $416.54
- JKS N/A
- Revenue Next Year
- STOK N/A
- JKS $31.21
- P/E Ratio
- STOK $25.02
- JKS N/A
- Revenue Growth
- STOK 1218.82
- JKS N/A
- 52 Week Low
- STOK $5.35
- JKS $13.42
- 52 Week High
- STOK $24.60
- JKS $37.36
- Technical
- Relative Strength Index (RSI)
- STOK 73.55
- JKS 58.40
- Support Level
- STOK $18.80
- JKS $23.60
- Resistance Level
- STOK $24.60
- JKS $27.28
- Average True Range (ATR)
- STOK 1.23
- JKS 1.11
- MACD
- STOK 0.02
- JKS 0.16
- Stochastic Oscillator
- STOK 67.93
- JKS 62.86
About STOK Stoke Therapeutics Inc.
Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.
About JKS JinkoSolar Holding Company Limited (each representing 4)
JinkoSolar Holding Co Ltd is engaged in the photovoltaic industry. The firm has built a vertically integrated solar power product value chain, manufacturing from silicon wafers to solar modules. It sells solar modules under the JinkoSolar brand. The company's products include Silicon wafers, Solar cells, and Solar modules. Its geographical segments are China (including Hong Kong and Taiwan), North America, Europe, Asia Pacific, and the Rest of the world.